DC Funds, LP - WEREWOLF THERAPEUTICS INC ownership

WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 46 filers reported holding WEREWOLF THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
DC Funds, LP ownership history of WEREWOLF THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,260,678
-29.8%
589,1020.0%25.95%
-32.2%
Q2 2023$1,796,761
+17.3%
589,1020.0%38.27%
+7.3%
Q1 2023$1,531,665
+26.8%
589,1020.0%35.68%
+9.1%
Q4 2022$1,207,659
-54.5%
589,1020.0%32.70%
-18.4%
Q3 2022$2,657,000
+10.3%
589,1020.0%40.05%
+20.5%
Q2 2022$2,409,000
-7.1%
589,1020.0%33.24%
-1.3%
Q1 2022$2,592,000
-62.5%
589,102
+1.4%
33.68%
-17.8%
Q4 2021$6,919,000
-31.6%
580,902
-1.4%
40.97%
+3.2%
Q3 2021$10,109,000
-1.6%
589,1020.0%39.69%
-18.7%
Q2 2021$10,274,000589,10248.81%
Other shareholders
WEREWOLF THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DC Funds, LP 589,102$2,409,00033.24%
MPM ASSET MANAGEMENT LLC 4,284,172$17,522,0007.39%
MPM BioImpact LLC 2,388,011$9,767,0002.71%
RA Capital Management 4,291,881$17,554,0000.47%
PFM Health Sciences, LP 1,730,723$7,079,0000.27%
SPHERA FUNDS MANAGEMENT LTD. 597,003$2,442,0000.26%
Oasis Management Co Ltd. 246,305$1,007,0000.18%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 958,125$3,919,0000.08%
Rubric Capital Management LP 204,996$838,0000.04%
Laurion Capital Management LP 535,160$2,189,0000.03%
View complete list of WEREWOLF THERAPEUTICS INC shareholders